NEO-ADJUVANT 177LU-PSMA-I&T RADIONUCLIDE IN HIGH-RISK PROSTATE CANCER BEFORE RADICAL PROSTATECTOMY: A FEASIBILITY TRIAL

被引：0
|
作者：
Frumer, Michael
Rosenbaum, Eli
Kedar, Daniel
Zohar, Yarden
Baniel, Jack
Steinmetz, Adam
Bernstine, Hanna
Groshar, David
Golan, Shay
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP15-20
引用
收藏
页码：E271 / E271
页数：1
相关论文
共 50 条
  • [31] Radiotherapy before and after radical prostatectomy for high-risk and locally advanced prostate cancer
    Perez, Bradford A.
    Koontz, Bridget F.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (05) : 226 - 234
  • [32] Positive treatment outcomes of erratic Liver metastases in end-stage metastatic prostate cancer with Radioligand therapy of 177Lu-PSMA-I&T
    Vyas, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S388 - S388
  • [33] Non-specific and paradoxical effects of neo-adjuvant PS341 after radical prostatectomy in high-risk patients
    Ayala, G
    Li, R
    Thompson, TC
    Lynch, GR
    Mims, MP
    Frolov, A
    Hayes, T
    Wheeler, T
    Miles, BJ
    Kadmon, D
    LABORATORY INVESTIGATION, 2006, 86 : 129A - 129A
  • [34] Non-specific and paradoxical effects of neo-adjuvant PS341 after radical prostatectomy in high-risk patients
    Ayala, GE
    Li, R
    Thompson, TC
    Lynch, GR
    Mims, MP
    Frolov, A
    Hayes, T
    Wheeler, TM
    Miles, BJ
    Kadmon, D
    MODERN PATHOLOGY, 2006, 19 : 129A - 129A
  • [35] 177Lu-PSMA-I&T Radioligand Therapy for Treating Metastatic Castration-Resistant Prostate Cancer: A Single-Centre Study in East Asians
    Bu, Ting
    Zhang, Lulu
    Yu, Fei
    Yao, Xiaochen
    Wu, Wenyu
    Zhang, Pengjun
    Shi, Liang
    Zang, Shiming
    Meng, Qingle
    Ni, Yudan
    Shao, Guoqiang
    Qiu, Xuefeng
    Ai, Shuyue
    Jia, Ruipeng
    Guo, Hongqian
    Wang, Feng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [36] Adjuvant and salvage treatment options for patients with high-risk prostate cancer treated with radical prostatectomy
    A S Kibel
    J B Nelson
    Prostate Cancer and Prostatic Diseases, 2007, 10 : 119 - 126
  • [37] Adjuvant chemotherapy and/or hormone therapy after radical prostatectomy for high-risk prostate cancer.
    Paule, B
    de la Taille, A
    PROGRES EN UROLOGIE, 2005, 15 (02): : 208 - 212
  • [38] Adjuvant and salvage treatment options for patients with high-risk prostate cancer treated with radical prostatectomy
    Kibel, A. S.
    Nelson, J. B.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2007, 10 (02) : 119 - 126
  • [39] Adjuvant vs Salvage Radiation Therapy for High-Risk Prostate Cancer Following Radical Prostatectomy
    MacDuffie, Emily
    D'Amico, Anthony V.
    JAMA ONCOLOGY, 2020, 6 (08) : 1165 - 1166
  • [40] Chemotherapy and novel therapeutics before radical prostatectomy for high-risk clinically localized prostate cancer
    Cha, Eugene K.
    Eastham, James A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (05) : 217 - 225
12345